Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Neurostimulation an Adjuvant Postoperative Analgesic in Total Knee Replacement (TKR) Surgeries

NCT: NCT05416294 · WITHDRAWN

NCT IDNCT05416294
StatusWITHDRAWN
Start Date2022-08-15
Completion2024-12-30
SponsorDyAnsys, Inc. (INDUSTRY)
First posted
Last updated

Brief Summary

To study and evaluate the effect of using the Primary Relief PENS treatment as adjuvant analgesia for reducing pain in total knee replacement (TKR) patients.

Frequently Asked Questions

What is Neurostimulation an Adjuvant Postoperative Analgesic in Total Knee Replacement (TKR) Surgeries?

Neurostimulation an Adjuvant Postoperative Analgesic in Total Knee Replacement (TKR) Surgeries is a clinical trial registered under NCT05416294. Current status: WITHDRAWN.

What is the status of NCT05416294?

The current status of NCT05416294 (Neurostimulation an Adjuvant Postoperative Analgesic in Total Knee Replacement (TKR) Surgeries) is: WITHDRAWN.

When did Neurostimulation an Adjuvant Postoperative Analgesic in Total Knee Replacement (TKR) Surgeries start?

Neurostimulation an Adjuvant Postoperative Analgesic in Total Knee Replacement (TKR) Surgeries started on 2022-08-15.

Related Devices

K213188Primary ReliefDyansys, Inc. K221425Primary ReliefDyansys, Inc. K170391ANSiStim-PPDyansys, Inc. K173861Drug ReliefDyansys, Inc. K202940First Relief v1Dyansys, Inc.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑